About 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine
6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine (PubChem CID 10122895) has the molecular formula C31H30BrN7O6S
and a molecular weight of 708.60 g/mol. Its IUPAC name is 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine.
Molecular Properties
| Compound Name | 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine |
| PubChem CID | 10122895 |
| Molecular Formula | C31H30BrN7O6S |
| Molecular Weight | 708.60 g/mol |
| Exact Mass | 707.12 |
| IUPAC Name | 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine |
| SMILES | COc1ccccc1Oc1c(NS(=O)(=O)Nc2ccc(C(C)C)cc2)nc(-c2ccncc2)nc1OCCOc1ncc(Br)cn1 |
| InChI | InChI=1S/C31H30BrN7O6S/c1-20(2)21-8-10-24(11-9-21)38-46(40,41)39-29-27(45-26-7-5-4-6-25(26)42-3)30(37-28(36-29)22-12-14-33-15-13-22)43-16-17-44-31-34-18-23(32)19-35-31/h4-15,18-20,38H,16-17H2,1-3H3,(H,36,37,39) |
| InChIKey | YSAYTYUCGQOQHZ-UHFFFAOYSA-N |
| XLogP | 6.24 |
| TPSA | 159.57 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
| MW ≤ 500 | 708.60 |
| LogP ≤ 5 | 6.24 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'sulfonamide_E(2)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Analyze 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine?
The IUPAC name of 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine (CID 10122895) is 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine.
What is the SMILES notation for 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine?
The canonical SMILES for 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine is COc1ccccc1Oc1c(NS(=O)(=O)Nc2ccc(C(C)C)cc2)nc(-c2ccncc2)nc1OCCOc1ncc(Br)cn1.
What is the InChIKey of 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine?
The InChIKey is YSAYTYUCGQOQHZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H30BrN7O6S/c1-20(2)21-8-10-24(11-9-21)38-46(40,41)39-29-27(45-26-7-5-4-6-25(26)42-3)30(37-28(36-29)22-12-14-33-15-13-22)43-16-17-44-31-34-18-23(32)19-35-31/h4-15,18-20,38H,16-17H2,1-3H3,(H,36,37,39).
What are the key properties of 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine?
6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine has a molecular weight of 708.60 g/mol, XLogP of 6.24, 14 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(2-methoxyphenoxy)-N-[(4-propan-2-ylphenyl)sulfamoyl]-2-pyridin-4-ylpyrimidin-4-amine is sourced from PubChem (CID 10122895), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).